نتائج بحث المؤلف :: APM

1

$The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group$

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM... حسب Roswitha Forstpointner

منشور في 2004

احصل على النص الكامل
Artigo

أضف إلى المفضلة

محفوظ في:
2

$Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)$

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, an... حسب Roswitha Forstpointner, Michael Unterhalt, Martin Dreyling, Hans-Peter Böck, Roland Repp, H. Wandt, Christiane Pott, John F. Seymour, Bernd Metzner, Annette Hänel, Thomas Lehmann, Frank Hartmann, Hermann Einsele, Wolfgang Hiddemann

منشور في 2006

احصل على النص الكامل احصل على النص الكامل
Artigo

أضف إلى المفضلة

محفوظ في:
3

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma حسب A. Herrmann, Eva Hoster, Thomas Zwingers, Günter Brittinger, M. Engelhard, P. Meusers, Marcel Reiser, Roswitha Forstpointner, Bernd Metzner, Norma Peter, Bernhard Wörmann, Lorenz Trümper, Michael Pfreundschuh, Hermann Einsele, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling

منشور في 2008

احصل على النص الكامل احصل على النص الكامل
Artigo

أضف إلى المفضلة

محفوظ في:
4

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety حسب Wolfgang Hiddemann, Anna Maria Barbui, Miguel Canales, Paul Cannell, Graham P. Collins, Jan Dürig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klánová, John Radford, John F. Seymour, Kensei Tobinai, Judith Trotman, Alis Burciu, Günter Fingerle‐Rowson, Marcel Wolbers, Tina Nielsen, Robert Marcus

منشور في 2018

احصل على النص الكامل
Artigo

أضف إلى المفضلة

محفوظ في:
5

Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network حسب Eva Hoster, Wolfram Klapper, Olivier Hermine, Hanneke C. Kluin‐Nelemans, Jan Walewski, Achiel Van Hoof, Marek Trněný, Christian H. Geisler, Francesco Di Raimondo, Michał Szymczyk, Stephan Stilgenbauer, Catherine Thiéblemont, Michael Hallek, Roswitha Forstpointner, Christiane Pott, Vincent Ribrag, Jeanette K. Doorduijn, Wolfgang Hiddemann, Martin Dreyling, Michael Unterhalt

منشور في 2014

احصل على النص الكامل احصل على النص الكامل
Artigo

أضف إلى المفضلة

محفوظ في:
6

Treatment of Older Patients with Mantle-Cell Lymphoma حسب Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Marek Trněný, Carsten Geisler, Stephan Stilgenbauer, Catherine Thiéblemont, Ursula Vehling‐Kaiser, Jeanette K. Doorduijn, Bertrand Coiffier, Roswitha Forstpointner, Hervé Tilly, Lothar Kanz, Pierre Feugier, Michał Szymczyk, Michael Hallek, Stephan Kremers, G. Lepeu, Laurence Sanhès, Josée M. Zijlstra, Réda Bouabdallah, Pieternella J. Lugtenburg, Margaret Macro, Michael Pfreundschuh, Vít Procházka, Francesco Di Raimondo, Vincent Ribrag, M. Uppenkamp, Marc André, W. Klapper, W. Hiddemann, Michael Unterhalt, Martin Dreyling

منشور في 2012

احصل على النص الكامل احصل على النص الكامل
Artigo

أضف إلى المفضلة

محفوظ في:
7

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial حسب Judith Trotman, Sally F. Barrington, David Belada, Michel Meignan, Robert MacEwan, Carolyn Owen, Václav Ptáčník, András Rosta, Günter Fingerle‐Rowson, Jiawen Zhu, Tina Nielsen, Deniz Şahin, Wolfgang Hiddemann, Robert Marcus, Andrew Davies, Mark Hertzberg, Andrew Grigg, Paul Cannell, Hang Quach, Stephen Opat, Constantine S. Tam, Paula Marlton, Ann Janssens, Fritz Offner, Koen Van Eygen, Randeep Sangha, Pam McKay, Jonathan Wilson, Richard van der Jagt, Daryl Roitman, Marek Trněný, Jiřı́ Mayer, Katell Le Dû, Philippe Solal‐Céligny, Guillaume Cartron, Charles Foussard, Norbert Frickhofen, Peter Schmidt, Ullrich Graeven, Tobias Gaska, Rudolf Schlag, Martin Sökler, Gabriele Prange‐Krex, Axel Florschütz, Hans‐Walter Lindemann, Christoph Schimmelpfennig, Solveig Tonndorf, Mathias Hänel, Georg Heß, Enrico Schalk, Heiko Hütten, Gottfried Doelken, Michael Pfreundschuh, Ulrich Keller, Michael Herold, Roswitha Forstpointner, Ursula Vehling‐Kaiser, Martin Hoffmann, Zita Borbényi, M. Udvardy, Judit Demeter, Alessandro Rambaldi, Enrica Morra, Federico Massimo, Ignazio Majolino, Monica Balzarotti, Gianpietro Semenzato, Miguel Canales, Francisco Javier Peñalver Párraga, Alfonso Soler Campos, Juan‐Manuel Sancho, José Antonio Márquez Navarro, Carlos Grande García, Herman Nilsson‐Ehle, Helen O. McCarthy, Chris Pocock, Shalal Sadullah, Ram Malladi, John Radford, Ed Kanfer, Anton Kruger, Dominic Culligan, Martin J.S. Dyer, Ruth Pettengell, John Seymour, John G. Gribben, Saad Al‐Ismail, F. N. Al‐Refaie, Norbert Blesing, Christopher Macnamara, Ann O’Callaghan, Andrew Haynes, George Follows, Roderick J. Johnson, David Cunningham, Kristian M. Bowles, Graham P. Collins, Eve Gallop‐Evans, Stephen Robinson, Chezhian Subash

منشور في 2018

احصل على النص الكامل
Artigo

أضف إلى المفضلة

محفوظ في: